US Stock MarketDetailed Quotes

SCPH scPharmaceuticals

Watchlist
  • 3.410
  • +0.060+1.79%
Close Nov 25 16:00 ET
  • 3.410
  • 0.0000.00%
Post 16:02 ET
170.64MMarket Cap-1748P/E (TTM)

scPharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
164.12%10.03M
391.70%8.05M
195.78%6.1M
13.59M
6.1M
3.8M
1.64M
2.06M
0
0
Operating revenue
164.12%10.03M
391.70%8.05M
195.78%6.1M
--13.59M
--6.1M
--3.8M
--1.64M
--2.06M
--0
--0
Cost of revenue
206.86%3.31M
549.72%2.3M
195.04%1.79M
3.81M
1.77M
1.08M
354K
605K
0
0
Gross profit
147.15%6.72M
348.13%5.75M
196.09%4.32M
9.78M
4.32M
2.72M
1.28M
1.46M
0
0
Operating expense
41.61%24.86M
34.30%20.19M
55.03%20.17M
80.26%65.18M
106.06%19.58M
75.65%17.56M
59.54%15.03M
79.72%13.01M
40.02%36.16M
41.38%9.5M
Selling and administrative expenses
50.83%21.32M
44.74%17.51M
60.12%17.45M
158.77%53.37M
126.34%16.24M
125.19%14.14M
182.68%12.1M
276.63%10.9M
110.79%20.62M
227.52%7.18M
-General and administrative expense
----
----
----
158.77%53.37M
----
----
----
----
110.79%20.62M
----
Research and development costs
3.51%3.54M
-8.76%2.68M
28.83%2.73M
-23.97%11.81M
43.51%3.34M
-7.99%3.42M
-42.94%2.93M
-51.32%2.12M
-3.15%15.53M
-48.65%2.33M
Operating profit
-22.29%-18.15M
-4.98%-14.43M
-37.23%-15.86M
-53.21%-55.4M
-60.57%-15.26M
-48.46%-14.84M
-45.91%-13.75M
-59.59%-11.55M
-40.02%-36.16M
-41.38%-9.5M
Net non-operating interest income expense
-24.77%-947K
-127.20%-1.47M
-89.47%-1.22M
-43.83%-3.02M
12.80%-967K
-423.45%-759K
-90.29%-647K
-27.92%-646K
16.90%-2.1M
-80.62%-1.11M
Non-operating interest income
-30.59%903K
-51.28%664K
-33.31%877K
324.27%5.1M
32.35%1.13M
460.78%1.3M
1,173.83%1.36M
10,015.38%1.32M
2,355.10%1.2M
12,042.86%850K
Non-operating interest expense
-10.19%1.85M
6.17%2.13M
7.14%2.1M
146.00%8.12M
6.79%2.09M
446.42%2.06M
349.66%2.01M
278.57%1.96M
28.23%3.3M
215.46%1.96M
Other net income (expense)
-44,377.78%-16.01M
-597.49%-1.19M
200.20%2.97M
154.23%3.61M
76.96%2.41M
-63.64%-36K
273.44%239K
6,971.43%990K
350.16%1.42M
7,917.65%1.36M
Special income (charges)
---13.03M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
--13.03M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
-8,177.78%-2.98M
-597.49%-1.19M
200.20%2.97M
154.23%3.61M
76.96%2.41M
-63.64%-36K
273.44%239K
6,971.43%990K
350.16%1.42M
7,917.65%1.36M
Income before tax
-124.54%-35.11M
-20.74%-17.09M
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
Income tax
Net income
-124.54%-35.11M
-20.74%-17.09M
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
Net income continuous Operations
-124.54%-35.11M
-20.74%-17.09M
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
Minority interest income
Net income attributable to the parent company
-124.54%-35.11M
-20.74%-17.09M
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-124.54%-35.11M
-20.74%-17.09M
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
Basic earnings per share
-82.93%-0.75
-22.22%-0.44
-20.00%-0.36
-9.23%-1.42
-16.67%-0.35
-10.81%-0.41
-2.86%-0.36
-7.14%-0.3
-27.45%-1.3
-11.11%-0.3
Diluted earnings per share
-82.93%-0.75
-22.22%-0.44
-20.00%-0.36
-9.23%-1.42
-16.67%-0.35
-10.81%-0.41
-2.86%-0.36
-7.14%-0.3
-27.45%-1.3
-11.11%-0.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 164.12%10.03M391.70%8.05M195.78%6.1M13.59M6.1M3.8M1.64M2.06M00
Operating revenue 164.12%10.03M391.70%8.05M195.78%6.1M--13.59M--6.1M--3.8M--1.64M--2.06M--0--0
Cost of revenue 206.86%3.31M549.72%2.3M195.04%1.79M3.81M1.77M1.08M354K605K00
Gross profit 147.15%6.72M348.13%5.75M196.09%4.32M9.78M4.32M2.72M1.28M1.46M00
Operating expense 41.61%24.86M34.30%20.19M55.03%20.17M80.26%65.18M106.06%19.58M75.65%17.56M59.54%15.03M79.72%13.01M40.02%36.16M41.38%9.5M
Selling and administrative expenses 50.83%21.32M44.74%17.51M60.12%17.45M158.77%53.37M126.34%16.24M125.19%14.14M182.68%12.1M276.63%10.9M110.79%20.62M227.52%7.18M
-General and administrative expense ------------158.77%53.37M----------------110.79%20.62M----
Research and development costs 3.51%3.54M-8.76%2.68M28.83%2.73M-23.97%11.81M43.51%3.34M-7.99%3.42M-42.94%2.93M-51.32%2.12M-3.15%15.53M-48.65%2.33M
Operating profit -22.29%-18.15M-4.98%-14.43M-37.23%-15.86M-53.21%-55.4M-60.57%-15.26M-48.46%-14.84M-45.91%-13.75M-59.59%-11.55M-40.02%-36.16M-41.38%-9.5M
Net non-operating interest income expense -24.77%-947K-127.20%-1.47M-89.47%-1.22M-43.83%-3.02M12.80%-967K-423.45%-759K-90.29%-647K-27.92%-646K16.90%-2.1M-80.62%-1.11M
Non-operating interest income -30.59%903K-51.28%664K-33.31%877K324.27%5.1M32.35%1.13M460.78%1.3M1,173.83%1.36M10,015.38%1.32M2,355.10%1.2M12,042.86%850K
Non-operating interest expense -10.19%1.85M6.17%2.13M7.14%2.1M146.00%8.12M6.79%2.09M446.42%2.06M349.66%2.01M278.57%1.96M28.23%3.3M215.46%1.96M
Other net income (expense) -44,377.78%-16.01M-597.49%-1.19M200.20%2.97M154.23%3.61M76.96%2.41M-63.64%-36K273.44%239K6,971.43%990K350.16%1.42M7,917.65%1.36M
Special income (charges) ---13.03M------------------0----------------
-Less:Other special charges --13.03M------------------------------------
Other non- operating income (expenses) -8,177.78%-2.98M-597.49%-1.19M200.20%2.97M154.23%3.61M76.96%2.41M-63.64%-36K273.44%239K6,971.43%990K350.16%1.42M7,917.65%1.36M
Income before tax -124.54%-35.11M-20.74%-17.09M-25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M
Income tax
Net income -124.54%-35.11M-20.74%-17.09M-25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M
Net income continuous Operations -124.54%-35.11M-20.74%-17.09M-25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M
Minority interest income
Net income attributable to the parent company -124.54%-35.11M-20.74%-17.09M-25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -124.54%-35.11M-20.74%-17.09M-25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M
Basic earnings per share -82.93%-0.75-22.22%-0.44-20.00%-0.36-9.23%-1.42-16.67%-0.35-10.81%-0.41-2.86%-0.36-7.14%-0.3-27.45%-1.3-11.11%-0.3
Diluted earnings per share -82.93%-0.75-22.22%-0.44-20.00%-0.36-9.23%-1.42-16.67%-0.35-10.81%-0.41-2.86%-0.36-7.14%-0.3-27.45%-1.3-11.11%-0.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data